Thyroid cancer in patients with hyperthyroidism

Hormone and Metabolic Research

Volumn 44, Issue 4, 2012, Pages 255-262

  Pazaitou Panayiotou, K ^a   Michalakis, K ^b   Paschke, R ^c  

^a THEAGENIO CANCER HOSPITAL   (Greece)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Graves' disease; hot nodules; hyperthyroidism; thyroid cancer; toxic multinodular goiter

Indexed keywords

CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; DISEASE ASSOCIATION; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MEDLINE; PRIORITY JOURNAL; REVIEW; THYROID CANCER; THYROID NODULE; TOXIC GOITER;

ANIMALS; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; THYROID NEOPLASMS;

EID: 84859456781     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1299741     Document Type: Review

References (106)

1. Means J H. The thyroid and its diseases. Philadelphia JB Lippincott Co: 1937; 482
2. Sokal J E. Incidence of malignancy in toxic and non-toxic nodular goiter. JAMA: 1954; 154 1321 1325
3. Beahrs O H, Pemberton J, Black B M. Nodular goiter and malignant lesion of the thyroid gland. J Clin Endocrinol: 1951; 11 1157 1165
4. Olen E, Klinck G H. Hyperthyroidism and thyroid cancer. Arch Pathol: 1966; 81 531 535
5. Shapiro S J, Friedmam N B, Perzik S L, Catz B. Incidence of thyroid carcinoma in Graves' disease. Cancer: 1970; 26 1261 1270
6. Davies L, Welch H G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA: 2006; 295 2164 2167
7. Enewold L, Zhu K, Ron E, Marrogi A J, Stojadinovic A, Peoples G E, Devesa S S. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev: 2009; 18 784 791
8. Cappelli C, Braga M, Martino E D, Castellano M, Gandossi E, Agosti B, Cumetti D, Pirola I, Mattanza C, Cherubini L, Rosei E A. Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: Experience at an Endocrine Center in Italy. Surg Today: 2006; 36 125 130 (Pubitemid 43163393)
9. Mazzaferri E L. Thyroid cancer and Graves's disease. J Clin Endocrinol Metab: 1990; 70 826 829
10. Ozaki O, Ito K, Kobayashi K, Toshima K, Iwasaki H, Yashiro T. Thyroid carcinoma in Graves' disease. World J Surg: 1990; 14 437 441 (Pubitemid 20299946)
11. Pazaitou-Panayiotou K, Perros P, Boudina M, Drimonitis A, Siardos G, Patakiouta F, Vainas I. Mortality from thyroid cancer in patients with hyperthyroidism: the Theagenion Cancer Hospital experience. Eur Journal Endocrinol: 2008; 159 799 803
12. Hayes F J, Sheaham K, Heffernan A, McKenna T J. Aggressive thyroid cancer associated with toxic nodular goitre. Eur J Endocrinol: 1996; 134 366 370 (Pubitemid 26109416)
13. Hales I B. McElduff Crummer P, Clifton-Bligh P, Delbridge L, Hoschl R, Poole A, Reeve T S, Wilmshurst E, Wiseman J. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer. J Clin Endocrinol Metab: 1992; 75 886 889
14. Pacini F, DiCoscio G C, Anelli S, Macchia E, Concetti R, Miccoli P, Arganini M, Pinchera A. Thyroid carcinoma in thyrotoxicosis patients treated by surgery. J Endocrinol Invest: 1988; 11 107 112 (Pubitemid 18070528)
15. Taneri F, Kurukahvecioglu O, Ege B, Yilmaz U, Tekin E H, Cifter C, Onuk E. Clinical presentation and treatment of hyperthyroidism associated with thyroid cancer. Endocr Regul: 2005; 39 91 96 (Pubitemid 44788387)
16. Sahin M, Guvener N D, Ozer F, Sengul A, Ertugrul D, Tutuncu N B. Thyroid cancer in hyperthyroidism: incidence rates and value of ultrasound-guided fine-needle aspiration biopsy in this patient group. J Endocrinol Invest: 2005; 28 815 818 (Pubitemid 43162837)
17. Senyurek Giles Y, Tunka F, Boztepe H, Kapran Y, Terzioglu T, Tezelman S. The risk factors for malignancy in surgically treated patients for Graves' disease, toxic multinodular goiter, and toxic adenoma. Surgery: 2008; 144 1028 1037
18. Cakir M, Arici C, Alakus H, Altunbas H, Balci M K, Karayalcin U. Incidental thyroid carcinoma in thyrotoxic patients treated by surgery. Horm Res: 2007; 67 96 99 (Pubitemid 46333778)
19. Terzioglou T, Tezelman S, Onaran Y, Tanakol R. Concurrent hyperthyroidism and thyroid carcinoma. Br J Surg: 1993; 80 1301 1302 (Pubitemid 23313166)
20. Linos D A, Karakitsos D, Papademetriou J. Should the primary treatment of hyperthyroidism be surgical? Eur J Surg: 1997; 163 651 657 (Pubitemid 27377441)
21. Vaiana R, Cappelli C, Perini P, Pinelli D, Camoni G, Farfaglia R, Balzano R, Braga M. Hyperthyroidism and concurrent thyroid cancer. Tumori: 1999; 85 247 252 (Pubitemid 29482210)
22. Gabriele R, Letizia C, Borghese M, De Toma G, Celi M, Izzo L, Cavallaro A. Thyroid cancer in patients with hyperthyroidism. Horm Res: 2003; 60 79 83 (Pubitemid 36928674)
23. Miccoli P, Minuto M N, Galleri D, D'Agostino J, Basolo F, Antonangeli L, Aghini-Lombardi F, Berti P. Incidental thyroid carcinoma in a large series of consecutive patients operated on for benign thyroid disease. ANZ J Surg: 2006; 76 123 126 (Pubitemid 43363011)
24. Lin C H, Chiang F Y, Wang L F. Prevalence of thyroid cancer in hyperthyroidism treated by surgery. Kaohsiung J Med Sci: 2003; 19 379 384
25. Zanella E, Rulli F, Muzi M, Sianesi M, Danese D, Sciacchitano S, Pontecorvi A. Prevalence of thyroid cancer in hyperthyroid patients treated by surgery. World J Surg: 1998; 22 473 478 (Pubitemid 28169604)
26. Cal P G, Tatti A, Farris S, Malloci A, Nicolosi A. Differentiated thyroid carcinoma and hyperthyroidism: a frequent association? Chir Ital: 2005; 57 193 197
27. Fukunaga F H, Lockett L J. Thyroid carcinoma in the Japanese in Hawaii. Arch Pathol: 1971; 92 6 13
28. Fukunaga F H, Yatani R. Geographic pathology of occult thyroid carcinomas. Cancer: 1975; 36 1095 1099
29. Habra M A, Hijazi R, Verstovsek G, Marcell M. Medullary thyroid carcinoma associated with hyperthyroidism: a case report and review of the literature. Thyroid: 2004; 14 391 396 (Pubitemid 38756660)
30. Alagöl F, Tanakol R, Boztepe H, Kapran Y, Terzioglu T, Dizdaroglu F. Anaplastic thyroid cancer with transiet thyrotoxicosis: case report and literature review. Thyroid: 1999; 9 1029 1032 (Pubitemid 29521989)
31. Belfiore A, Garofalo M R, Giuffrida D, Runello F, Filetti S, Fiumara A, Ippolito O, Vigneri R. Increased aggressiveness of thyroid cancer in patients with Graves' disease. J Clin Endocrinol Metab: 1990; 70 830 835
32. Pellegriti G, Belfiore A, Giuffrida D, Lupo L. Vigneri Outcome of Differentiated Thyroid Cancer in Graves' Patients. J Clin Endocrinol Metab: 1998; 83 2805 2809 (Pubitemid 28493780)
33. Yeo P P, Wang K W, Sinniah R, Aw T C, Chang C H, Sethi V K, Tan B C, Lim P. Thyrotoxicosis and thyroid cancer. Aust N Z J Med: 1982; 12 598 593
34. Farbota L M, Calandra D B, Lawrence A M, Paloyan R. Thyroid carcinoma in Graves' disease. Surgery: 1985; 98 1145 1152
35. Lee J, Nam K H, Chung W Y, Soh E Y, Park C S. Clinicopathologic features and treatment outcomes in differentiated thyroid carcinoma patients with concurrent Graves' disease. J Korean Med Sci: 2008; 23 796 801
36. Foppiani L, Del Monte P, Marugo A, Arlandini A, Sartini G, Marugo M, Bernasconi D. Heterogeneous malignancy in toxic thyroid nodule, letter to the Editor. J Endocrinol Invest: 2005; 28 294 295 (Pubitemid 43162780)
37. Gerenova J, Buysschaert M, de Burbure C Y, Daumerie C. Prevalence of thyroid cancer in Graves's disease: a retrospective study of a cohort of 103 patients treated surgically. Eur J Intern Med: 2003; 14 321 325 (Pubitemid 37108727)
38. Erbil Y, Barbaros U, Ozbey N, Kapran Y, Tükenmez M, Bozbora A, Ozarmaan S. Graves' disease, with and without nodules, and the risk of thyroid carcinoma. J Laryngl Otol: 2008; 122 291 295 (Pubitemid 351364367)
39. Kraimps J L, Bouin-Pincau M H, Mathonnet M, De Calan L, Ronceray J, Visset J, Marechaud R, Barbier J. Multicentre study of thyroid nodules in patients with Graves' disease. Br J Surg: 2000; 87 1111 1113 (Pubitemid 30496865)
40. Behar R, Arganini M, Wu T C, McCormick M, Straus F H, DeGroot L J, Kaplan E L. Graves' disease and thyroid cancer. Surgery: 1986; 100 1121 1127 (Pubitemid 17223230)
41. Ain K B. Papillary thyroid carcinoma - etiology, assessment and therapy. Endocrinol Metab Clin North Am: 1995; 24 711 760
42. Kikuchi S, Noguchi S, Yamashita H, Uchino S, Kawamoto H. Prognosis of small thyroid cancer in patients with Graves' disease. Br J Surg: 2006; 93 434 439
43. Stocker D J, Burch H B. Thyroid cancer yield in patients with Graves' disease. Minerva Endocrinol: 2003; 28 205 212
44. Kim W B, Han S M, Kim T Y, Nam-Goong I S, Gong G, Lee H K, Hong S J, Shong Y K. Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease. Clin Endocrinol (Oxf): 2004; 60 719 725 (Pubitemid 38788080)
45. Edmonds C J, Tellez M. Hyperthyroidism and thyroid cancer. Clin Endocrinol (Oxf): 1998; 28 253 259
46. Yano Y, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K, Ito K. Recent outcome of Graves' disease patients with papillary thyroid cancer. Eur J Endocrinol: 2007; 157 325 329 (Pubitemid 47603537)
47. Duh Q Y. Thyroid cancer in Graves' disease: incidental cancer versus clinical cancer. Ann Surg Oncol: 2004; 11 356 357
48. Phitayakorn R, McHenry C R. Incidental thyroid carcinoma in patients with Graves' disease. Am J Surg: 2008; 195 292 297 (Pubitemid 351625108)
49. Chao T C, Lin J D, Chen M F. Surgical treatment of thyroid cancers with concurrent Graves disease. Ann Surg Oncol: 2004; 11 407 412
50. Belfiore A, La Rosa G L, La Porta G A, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R. Cancer risk in patients with cold thyroid nodules. Relevance of iodine intake, sex, age and multinodularity. Am J Med: 1992; 93 363 369
51. Welker M J, Orlov D. Thyroid Nodules. Am Fam Phycisian: 2003; 67 3
52. Mazzaferri E L. Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med: 1992; 93 359 362
53. Belfiore A, Russo D, Vigneri R, Filetti S. Graves' disease, thyroid nodules and thyroid cancer. Clin Endocrinol: 2001; 55 711 718 (Pubitemid 34008739)
54. Stocker D J, Foster S S, Solomon B L, Shriver C D, Burch H B. Thyroid cancer yield in patients with Graves' disease selected for surgery on the basis of cold scintiscan defects. Thyroid: 2002; 12 305 311 (Pubitemid 34438934)
55. Gharib H, Papini E, Paschke R, Duick D S, Valcalvi R, Hegedüs L, Vitti P. AACE/AME/ETA Task Force on Thyroid Nodules 2010 American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules executive summary and recommendations. J Endocrinol Invest: 2010; 33 287 291; Hot Thyroidology 4: 1-88; Endocr Pract 16 (Suppl 1): 1-43
56. Centeno B A, Szyfelbein W M, Daniels G H, Vickery A L Jr. Fine needle aspiration biopsy of the thyroid gland in patients with prior Graves' disease treated with radioactive iodine. Morphologic findings and potential pitfalls. Acta Cytol: 1996; 40 1189 1197 (Pubitemid 26424472)
57. Anderson S R, Mandel S, LiVolsi V A, Gupta P K, Baloch Z W. Can cytomorphology differentiate between benign nodules and tumors arising in Graves' disease? Diagn Cytopathol: 2004; 31 64 67 (Pubitemid 38857502)
58. Ozaki O, Ito K, Mimura T, Sugino K, Kitamura Y, Iwabuchi H, Kawano M. Thyroid carcinoma after radioactive iodine therapy for Graves' disease. World J Surg: 1994; 18 518 521 (Pubitemid 24273850)
59. Rees Smith B, McLachlan S M, Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr Rev: 1988; 9 106 121
60. Filetti S, Belfiore A, Amir S M, Daniels G H, Ippolito O, Vigneri R, Ingbar S H. The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer. N Engl J Med: 1988; 318 753 759 (Pubitemid 18090258)
61. Morshed S A, Latif R, Davies T F. Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology: 2009; 150 519 529
62. Noguchi S, Yamashita H, Murakami N, Nakayama I, Toda M, Kawamoto H. Small carcinomas of the thyroid: a long-term follow-up of 867 patients. Arch Surg: 1996; 131 187 191 (Pubitemid 26053907)
63. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW A, Wiersinga W. and the European Thyroid cancer Taskforce European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol: 2006; 154 787 803 (Pubitemid 43997716)
64. Cooper D S, Doherty G M, Haugen B R, Kloos R T, Lee S L, Mandel S J, Mazzaferri E L, Mclver B, Sherman S I, Tuttle R M. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid: 2006; 16 109 142
65. Cooper D S, Doherty G M, Haugen B R, Kloos R T, Lee S L, Mandel S J, Mazzaferri E L, McIver B, Pacini F, Schlumberger M, Sherman S I, Steward D L, Tuttle R M. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid: 2009; 19 1167 1214
66. Stlberg P, Svensson A, Hessman O, Akerström G, Hellman P. Surgical treatment of Graves' disease: evidence-based approach. World J Surg: 2008; 32 1269 1277
67. Ikekubo K, Hino M, Ito H, Otami M, Yamaguchi H, Saiki Y, Ui K, Habuchi Y, Ishihsra T, Mori T. Thyroid carcinoma in solitary hot thyroid lesions on Tc-99m sodium pertechnetat scans. Ann Nucl: 1989; Med 3 31 36 (Pubitemid 19111499)
68. Uludag M, Yetkin G, Citgez B, Isgor A, Basak T. Autonomously functioning thyroid nodule treated with radioactive iodine and later diagnosed as papillary thyroid cancer. Hormones (Athens): 2008; 7 175 179
69. Cirillo R L Jr, Pozderac R V, Caniano D A, Falko J M. Metastatic pure papillary thyroid carcinoma presenting as a toxic hot nodule. Clin Nucl Med: 1998; 23 345 349 (Pubitemid 28249272)
70. Majima T, Doi K, Komatsu Y, Itoh H, Fukao A, Shigemoto M, Takagi C, Corners J, Mizuta N, Kato R, Nakao K. Papillary thyroid carcinoma without metastases manifesting as an autonomously functioning thyroid nodule. Endocr J: 2005; 52 309 316 (Pubitemid 41003522)
71. Low S C, Sinha A K, Sundram F X. Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography. Singapore Med J: 2005; 46 304 307 (Pubitemid 40756548)
72. Ahuja S, Ernst H. Hyperthyroidism and thyroid carcinoma. Acta Endocrinol (Copenh): 1991; 124 146 151
73. Mizukami Y, Michigishi T, Nonomura A, Yokoyama K, Noguchi M, Hashimoto T, Nakamura S, Ishizaki T. Autonomously functioning (hot) nodule of the thyroid gland. A clinical and histopathologic study of 17 cases. Am J Clin Pathol: 1994; 101 29 35 (Pubitemid 24030374)
74. Hamburger J I. Solitary autonomously functioning thyroid lesions. Diagnosis, clinical features and pathogenetic considerations. Am J Med: 1975; 58 740 748
75. Goretzki P, Wahl R A, Branscheid D, Joseph K, Tsuchiya A, Roher H D. Indication for operation of patients with autonomously functioning thyroid tissue in endemic goiter areas. World J Surg: 1985; 9 149 155 (Pubitemid 15106701)
76. Harach H R, Sanchez S S, Williams E D. Pathology of the autonomously functioning (hot) thyroid nodule. Ann Diagn Pathol: 2002; 6 10 19 (Pubitemid 34157741)
77. Smith M, McHenry C, Jarosz H, Lawrence A M, Paloyan E. Carcinoma of the thyroid in patients with autonomous nodules. Am Surg: 1988; 54 488 489
78. Schröder S, Marthaler B. Autonomy and malignancy of thyroid glad tumors. A critical analysis of the literature on the existence of hyperfunctioning follicular and papillary thyroid gland carcinomas. Pathologe: 1996; 17 349 357 (Pubitemid 26333700)
79. Daumerie C, Ayoubi S, Rahier J, Buysschaert M, Squifflet J P. Prevalence of thyroid cancer in hot nodules. Ann Chir: 1998; 52 444 448 (Pubitemid 28264444)
80. Croom R D 3rd, Thomas C G Jr, Reddick R L, Tawil M T. Autonomously functioning thyroid nodules in childhood and adolescence. Surgery: 1987; 102 1101 1108 (Pubitemid 18010759)
81. Niedziela M, Breborowicz D, Trejster E, Korman E. Hot nodules in children and adolescents in western Poland from 1996 to 2000: clinical analysis of 31 patients. J Paediatr Endocrinol Metab: 2002; 15 823 830 (Pubitemid 34704835)
82. Als C, Gedeon P, Rosler H, Minder C, Netzer P, Laissue J A. Survival analysis of 19 patients with toxic thyroid carcinoma. J Clin Endocrinol Metab: 2002; 87 4122 4127
83. Niepomniszcze H, Suarez H, Pitoia F, Pignatta A, Danilowicz K, Manavela M, Elsner B, Bruno O D. Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620l) and a mutation of Ki-RAS (G12C) genes. Thyroid: 2006; 16 497 503
84. Spambalg D, Sharifi N, Elisei R, Gross J L, Medeiros-Neto G, Fagin J A. Structural studies of the thyrotropin receptor and GS in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation. J Clin Endocrinol Metab: 1996; 81 3898 3901 (Pubitemid 26380393)
85. Russo D, Tumino S, Arturi F, Vigneri P, Grasso G, Pontecorvi A, Filetti S, Belfiore A. Detection of an activation mutation of the thyrotropin receptor in a case of autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab: 1997; 82 735 738 (Pubitemid 27106579)
86. Russo D, Wong M G, Costance G, Chiefari E, Treseler P A, Arturi F, Filetti S, Clark O H. A Val 677 activating mutation of the thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis. Thyroid: 1999; 9 13 17 (Pubitemid 29081144)
87. Camacho P, Gordon D, Chiefari E, Yong S, Dejong S, Pitale S, Russo D, Filetti S. A Phe 486 Thyrotropin receptor mutation in an autonomously functioning folliculer carcinoma that was causing hyperthyroidism. Thyroid: 2000; 10 1009 1012 (Pubitemid 32104088)
88. Mircescu H, Parma J, Huot C, Deal C, Oligny L L, Vassart G, Van Vliet G. Hyperfunctioning malignant thyroid nodule in an 11-year-old girl: pathologic and molecular studies. J Pediatr: 2000; 137 585 587
89. Fuhrer D, Tannapfel A, Sabri O, Lamesch P, Paschke R. Two somatic TSH receptor mutations in a patient with toxic metastasising follicular thyroid carcinoma and non-functional lung metastases. Endocr Relat Cancer: 2003; 10 591 600 (Pubitemid 38094893)
90. Gozu H, Avsar M, Bircan R, Sahin S, Ahiskanali R, Gulluoglu B, Deyneli O, Ones T, Narin Y, Akalin S, Cirakoglu B. Does a Leu 512 Arg thyrotropin receptor mutation cause an autonomously functioning papillary carcinoma? Thyroid: 2004; 14 975 980 (Pubitemid 39612919)
91. Jaeschke H, Mueller S, Eszlinger M, Paschke R. Lack of in vitro constitutive activity for three previously reported TSH receptor mutations identified in patients with non autoimmune hyperthyroidism and hot thyroid carcinomas. Clin Endocrinol (Oxf): 2010; 73 815 820
92. Cerci C, Cerci S S, Eroglu E, Dede M, Kapucuoglu N, Yildiz M, Bulbul M. Thyroid cancer in toxic and non-toxic multinodular goiter. J Postgrad Med: 2007; 53 157 160 (Pubitemid 47281968)
93. Chigot J P, Mngaux F, Keopadabsy K, Hoang C, Aurengo A, Leenhardt L, Turpin G. Thyroid cancer in patients with hyperthyroidism. Presse Med: 2000; 29 1969 1972
94. Lian X, Bai Y, Tang W, Dai W, Guo Z. A clinical study on coincidence with hyperthyroidism and thyroid carcinoma. Zhongguo Yi Xue Ke Xue Yuan Xue Bao: 2000; 22 273 275
95. Ruggieri M, Scocchera F, Genderini M, Mascaro A, Luongo B, Paolini A. Hyperthyroidism and concurrent thyroid carcinoma. Eur Rev Med Pharmacol Sci: 1999; 3 265 268 (Pubitemid 32154181)
96. Omür O, Yazc B, Akgün A, Ozcan Z, Akyldz M, Argon M, Ozkl H. Concomitant hyperthyroidism in patients with thyroid carcinoma and the effects of iodine supplementation in an iodine-deficient Area. Clin Nucl Med: 2008; 33 769 772
97. Kilpatrick R, Blomfield G W, Neal F E, Wilson G M. Carcinoma of the thyroid. J Med: 1957; 26 209 233
98. Hancock B W, Bing R F, Dirmikis S M, Munro D S, Neal F E. Thyroid carcinoma and concurrent hyperthyroidism. Cancer: 1997; 39 298 302
99. Mazzaferri E L, Young R L, Oertel J E, Kemmerer W T, Page C P. Papillary thyroid carcinoma: The impact of therapy in 576 patients. Medicine (Baltimore): 1977; 56 171 196 (Pubitemid 8111452)
100. Hall R, Ross M, Teng C S, Smith B R. Immunological aspects of thyroid cancer. Recent Results Cancer Res: 1980; 73 56 59
101. Wahl R A, Goretzki P, Meybier H, Nitschke J, Linder M, Roher H D. Coexistence of hyperthyroidism and thyroid cancer. World J Surg: 1982; 6 385 390 (Pubitemid 12068810)
102. Vini L, Hyer S, Pratt B, Harmer C. Good prognosis in thyroid cancer found incidentally at surgery for thyrotoxicosis. Postgrad Med J: 1999; 75 169 170 (Pubitemid 29097473)
103. Bolko P, Lacka K, Manuszewska E, Ruchala M, Majewski P, Sowinski J. Is hyperthyroidism often present in patients with thyroid differentiated carcinoma? Pol Arch Med Weun: 2002; 107 555 559
104. Gulcelik M A, Gulcelik N E, Dinc S, Kuru B, Camlibel M, Alagol H. The incidence of hyperthyroidism in patients with thyroid cancer in an area of iodine deficiency. J Surg Oncol: 2006; 94 35 39 (Pubitemid 43967720)
105. Zhu X G, Cheng S Y. Modeling thyroid cancer in the mouse. Horm Metab Res: 2009; 41 488 499
106. Frates M C, Benson C B, Charboneau J W, Cibas E S, Clark O H, Coleman B G, Cronan J J, Doubilet P M, Evans D B, Goellner J R, Hay I D, Hertzberg B S, Intenzo C M, Jeffrey R B, Langer J E, Larsen P R, Mandel S J, Middleton W D, Reading C C, Sherman S I, Tessler F N. Society of Radiologists in Ultrasound Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology: 2005; 237 794 800 (Pubitemid 41636365)